Effect of beta -adrenergic agonist and resistance training on maximal oxygen uptake and muscle oxidative enzymes in men.

Clicks: 587
ID: 14409
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #1 of 27 articles by views in Scandinavian journal of medicine & science in sports

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
While beta -adrenoceptor stimulation has been shown to increase lean mass and to alter metabolic properties of skeletal muscle, adaptations in muscle oxidative enzymes and maximal oxygen uptake (V̇O ) in response to beta -adrenergic agonist treatment are inadequately explored in humans, particularly in association with resistance training. Herein we investigated beta -adrenergic-induced changes in V̇O , leg and arm composition, and muscle content of oxidative enzymes in response to treatment with the selective beta -adrenergic agonist terbutaline with and without concurrent resistance training in young men. Forty-six subjects were randomized to four weeks of lifestyle maintenance (n=23) or resistance training (n=23). Within the lifestyle maintenance and resistance training group, subjects received daily terbutaline (8·0.5 mg)(n=13) or placebo (n=10) treatment. No apparent treatment by training interactions were observed during the study period. Terbutaline increased leg and arm lean mass with the intervention, whereas no treatment differences were observed in absolute V̇O and incremental peak power output (iPPO). Treatment main effects were observed for V̇O -reserve (P<0.05), V̇O relative to body mass (P<0.05), V̇O relative to leg lean mass (P<0.01), and iPPO relative to leg lean mass, in which terbutaline had a negative effect compared to placebo. Furthermore, content of electron transport chain complex I-V decreased by 11% (P<0.05) for terbutaline compared to placebo. Accordingly, chronic treatment with the selective beta -adrenergic agonist terbutaline may negatively affect V̇O and iPPO in relative terms, but not in absolute. This article is protected by copyright. All rights reserved.
Reference Key
lemminger2019effectscandinavian Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Lemminger, Anders Krogh;Jessen, Søren;Habib, Sajad;Onslev, Johan;Xu, Stella Feng Sheng;Backer, Vibeke;Bangsbo, Jens;Hostrup, Morten;
Journal Scandinavian journal of medicine & science in sports
Year 2019
DOI
10.1111/sms.13544
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.